Related Experiment Video
Updated: Aug 17, 2026

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
Published on: September 9, 2021
PPAR-alpha: a key to the mechanism of hepatoprotection by clofibrate
1Department of Toxicology, College of Pharmacy, The University of Louisiana at Monroe, 700 University Avenue, Monroe, Louisiana 71209, USA.
Abstract:
The article highlighted in this issue is "Peroxisome Proliferator-Activated Receptor Alpha-Null Mice Lack Resistance to Acetaminophen Hepatotoxicity Following Clofibrate Exposure" by Chuan Chen, Gayle E. Hennig, Herbert E. Whiteley, J Christopher Corton, and José E. Manautou (pp. 338-344).
Insights
Peroxisome proliferator-activated receptor alpha (PPARα)-null mice did not gain protection against acetaminophen-induced liver injury after clofibrate treatment. This suggests PPARα is crucial for the protective effects of fibrates against drug-induced liver damage.
Area of Science:
- Hepatotoxicity Research
- Pharmacology
- Toxicology
Background:
- Acetaminophen overdose is a leading cause of acute liver failure.
- Fibrate drugs, like clofibrate, are known to protect against acetaminophen-induced liver injury.
- Peroxisome proliferator-activated receptor alpha (PPARα) is a key mediator of fibrate action.
Purpose of the Study:
- To investigate the role of PPARα in mediating the protective effects of clofibrate against acetaminophen hepatotoxicity.
- To determine if PPARα-null mice exhibit altered susceptibility to acetaminophen-induced liver injury.
Main Methods:
- Acetaminophen-induced liver injury model in wild-type and PPARα-null mice.
- Administration of clofibrate prior to acetaminophen challenge.
- Assessment of liver injury markers (ALT, AST), oxidative stress, and inflammatory responses.
Main Results:
- PPARα-null mice showed no resistance to acetaminophen hepatotoxicity after clofibrate exposure.
- Clofibrate treatment did not reduce liver injury in PPARα-null mice, unlike in wild-type controls.
- Key pathways involved in hepatoprotection were not activated in PPARα-null mice.
Conclusions:
- PPARα is essential for the hepatoprotective effects of clofibrate against acetaminophen-induced liver injury.
- Targeting PPARα may be a strategy to enhance protection against drug-induced liver damage.
More Related Videos
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: